Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS Framework Agreement for Branded medicines - London - Tranche B - Contracts Finder Opportunity

NHS England

This public procurement record has 2 releases in its history.

Award

01 Oct 2019 at 15:57

Award Notice
Tender

12 Mar 2019 at 14:43

Tender Notice
Summary of the contracting process

The NHS England is currently in the award stage of the NHS Framework Agreement for Branded Medicines, specifically for the London region and labelled as Tranche B. The contract, which has a total value of £251,930,337, is focused on pharmaceutical products, particularly Cytokine Modulators and monoclonal antibodies. The contract period begins on 1 September 2019 and runs until 31 August 2021, with potential extensions available for up to 24 months. The procurement method used for this tender is an open procedure above the threshold, and the tender period concluded on 4 April 2019.

This tender presents significant opportunities for businesses in the pharmaceutical sector, particularly those specialising in branded medicines, biotechnology, and healthcare products. Small and medium enterprises (SMEs) are encouraged to participate, particularly in the supply of innovative medicines, as evidenced by the eligible SME status noted in the tender details. Companies that provide Cytokine Modulators, monoclonal antibodies, or related pharmaceutical goods may find this contract particularly beneficial for growth and expansion in the competitive healthcare market.

How relevant is this notice?

Notice Information

Notice Title

NHS Framework Agreement for Branded medicines - London - Tranche B - Contracts Finder Opportunity

Notice Description

NHS Framework for the NHS London Region, Branded Medicines - Tranche B, Cytokine Modulators and other monoclonal Antibodies, and Antiretrovirals Offer reference number: CM/PHR/16/5515/01 - 1 September 2019 to 31 August 2021 - NHS Framework for the NHS London Region, Branded Medicines - Tranche B with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/16/5515/02 - 1 September 2019 to 31 August 2020 - NHS Framework for the NHS London Region, Branded Medicines - Annual Tranche - Cytokine Modulators and other monoclonal antibodies with an option to extend (at the Authority's discretion) for a period or periods up to a total of 12 months CM/PHR/16/5515/03 - 1 September 2019 to 31 August 2020 - NHS Framework for the NHS London Region, Branded Medicines - Antiretrovirals with an option to extend (at the Authority's discretion) for a period or periods up to a total of 12 months

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-aaa2bd9e-0fdb-4884-8fca-b0d29a6ed15a
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/8c5e39c1-07e5-4184-8320-981c952e4f28
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure (above threshold)
Tender Suitability
SME
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£251,930,337 £100M-£1B
Lots Value
Not specified
Awards Value
£251,930,337 £100M-£1B
Contracts Value
Not specified

Notice Dates

Publication Date
1 Oct 20196 years ago
Submission Deadline
4 Apr 2019Expired
Future Notice Date
Not specified
Award Date
5 Jul 20197 years ago
Contract Period
1 Sep 2019 - 31 Aug 2020 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
RUNCORN
Postcode
WA7 2ES
Postcode Area
Warrington
Country
England
Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD7 Merseyside
Small Region (ITL 3)
TLD71 East Merseyside
Delivery Location
TLI London
Local Authority
Halton
Electoral Ward
Halton Lea
Westminster Constituency
Runcorn and Helsby

Supplier Information

Number of Suppliers
30
Supplier Names

AbbVie Ltd

Amgen Ltd

Astellas Pharma Ltd

Aventis Pharma Ltd trading as Sanofi

Bristol-Myers Squibb Pharmaceuticals Ltd.

Daiichi Sankyo UK Ltd

ELI LILLY AND COMPANY LIMITED

Fannin UK Ltd T/A Kent Pharmaceuticals Ltd

Ferring Pharmaceutical

Gedeon Richter UK Ltd

Gilead Sciences Ltd

Ipsen Ltd

Janssen-Cilag Ltd

LEO Pharma

MYLAN UK HEALTHCARE LIMITED

Merck Serono Limited

Merck Sharp & Dohme (MSD)

Napp Pharmaceuticals Ltd

Novartis Pharmaceutical UK Ltd

Novo Nordisk Ltd

Pfizer Ltd

Pharmasure Limited

ROVI Biotech Limited

Roche Products Ltd

Sandoz Ltd

TAKEDA UK

Techdow Pharma England Limited

UCB Pharma Ltd

ViiV Healthcare Limited

Zentiva Pharma UK Limited

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...